Canada dry powdered inhaler market is anticipated to grow at a significant CAGR of around 6.8% during the forecast period. The major factors that are contributing significantly to the market growth include growing geriatric population susceptible to respiratory diseases such as asthma and COPD, and high healthcare expenditure. Asthma causes around 350 mortalities every year in the country and it is estimated that over 2 million people live in Canada with Asthma every year. Asthma rates have been increased in Canada over the last 20 years. Although, the fatality rate due to asthma has decreased slightly due to the availability of effective medications. COPD is another respiratory disorder that is the fourth most common cause of mortality in the country and particularly affects women. 

Request a Free Sample of our Report on Canada dry powdered inhaler market:  https://www.omrglobal.com/request-sample/canada-dry-powdered-inhaler-market

Canada dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. 

A full Report of Canada dry powdered inhaler market is Available at: https://www.omrglobal.com/industry-reports/canada-dry-powdered-inhaler-market

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing dry powdered inhalers to cater to a wide range of customers within the region and across the globe. The major players of the Canada inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, ResMed Corp. (Propeller Health), Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. 

Market Segmentation

Canada Dry Powdered Inhaler Market by Type

Preventive Dry Powdered Inhaler

Reliever Dry Powdered Inhaler

Long Acting Bronchodilators Inhaler 

Canada Dry Powdered Inhaler Market by Application

Asthma 

Chronic Obstructive Pulmonary Disease (COPD)

Canada Dry Powdered Inhaler Market by End-User

Homecare

Hospitals and Clinics

Company Profiles

3M Co.

Acorda Therapeutics, Inc.

Adamis Pharmaceuticals Corp.

Adherium Ltd.

Aradigm Corp.

AstraZeneca PLC

Boehringer Ingelheim International GmbH

Drive Devilbiss Healthcare LLC

GlaxoSmithKline PLC

Koninklijke Philips N.V.

Manta Devices LLC

Novartis AG

Omron Healthcare Inc.

ResMed Corp.

Pulmatrix Inc.

Savara, Inc.

Sunovion Pharmaceuticals

Teva Pharmaceuticals Industries Ltd.

 For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/canada-dry-powdered-inhaler-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +1 646-755-7667, +91 780-304-0404